MAIA Biotechnology (MAIA) Q1 2026 Earnings
MAIA·Reported May 11, 2026·Before market open
Diluted EPS came in at $-0.14 (+12.5% YoY), beat the $-0.18 consensus by $0.04.
Diluted EPS
$-0.14beat by $0.04
Consensus: $-0.18
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about MAIA Biotechnology's Q1 2026 earnings report.
MAIA Biotechnology (MAIA) reported Q1 2026 earnings on May 11, 2026 before market open.
MAIA Biotechnology reported diluted EPS of $-0.14 for Q1 2026.
EPS beat the consensus estimate of $-0.18 by $0.04.
Compared to the same quarter a year prior, diluted EPS grew 12.5% from $-0.16.
You can read the 10-Q periodic report (0001493152-26-022154) directly on SEC EDGAR. The filing index links above go to sec.gov.